Follow the people · Insider

KH

Kinney Horn

Insider · Chief Business Officer · IMNM

Kinney Horn files insider transactions with the SEC as a chief business officer of Immunome (IMNM). We hold 2 disclosed purchases and sales filed since 19 November 2020, 2 of them in the last 90 days.

  • Files forIMNM
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure6 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 20 February 20244 August 2026Chief Business Officer · Immunome (IMNM)13 Form 4 lines · source: SEC Form 4
  • Filed 10 June 20201 February 2023Chief Business Officer · Olema Pharmaceuticals (OLMA)46 Form 4 lines · source: SEC Form 4

Everything they disclosed

59 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.